Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled insulins.

Sujoy Ghosh1, Andrew Collier

  • 1Ayr Hospital, Dalmellington Road, Ayr, Ayrshire, UK.

Postgraduate Medical Journal
|March 9, 2007
PubMed
Summary
This summary is machine-generated.

Inhaled insulin offers similar glucose control to injections for diabetes patients, with potentially higher satisfaction. Further research is needed on long-term effects and cost-effectiveness of this novel pulmonary drug delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced peroxisomal function increases insulin secretion, promotes insulin oxidation, and impairs β cell maturity.

JCI insight·2026
Same author

Cross-tissue dual-omics analysis reveals molecular programs linked to myopia susceptibility and progression.

Life science alliance·2026
Same author

Evidence of Chiral Fermion Edge Modes through Geometric Engineering of Thermal Hall Effect in α-RuCl_{3}.

Physical review letters·2026
Same author

Maxillofacial tubercular osteomyelitis: diagnostic and therapeutic perspectives from a case series.

BMC infectious diseases·2026
Same author

Integrated care for type 1 diabetes: The West Bengal model: 24-month follow-up.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Trabecular Bone Score and Bone Turnover Markers Unmask Early Skeletal Fragility in Children and Adolescents With Type 1 Diabetes.

AACE endocrinology and diabetes·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
Same journal

Aids to venesection and parenteral drug administration in patients with difficult veins.

Postgraduate medical journal·2026
Same journal

Diagnostic reasoning in clinical neurology: a comprehensive primer.

Postgraduate medical journal·2026
See all related articles

Area of Science:

  • Pulmonary drug delivery systems
  • Diabetes management technologies
  • Inhaled pharmaceutical formulations

Background:

  • Leveraging expertise from asthma inhaler technology, pulmonary insulin delivery devices have been developed.
  • Aerosol particle size is a critical factor influencing the efficacy of pulmonary drug delivery.
  • Several companies are developing inhaled insulin systems, with Pfizer launching the first product, Exubera.

Purpose of the Study:

  • To evaluate the efficacy and patient experience of inhaled insulin compared to traditional methods.
  • To assess the potential of pulmonary insulin delivery for managing type 1 and type 2 diabetes.
  • To identify areas for further investigation regarding inhaled insulin use.

Main Methods:

  • Clinical trials were conducted involving patients with type 1 and type 2 diabetes.

Related Experiment Videos

  • Comparison of glucose control between inhaled insulin and subcutaneous insulin delivery.
  • Assessment of patient satisfaction with inhaled insulin therapy.

    • Main Results:

    • Inhaled insulin demonstrated comparable glycemic control to subcutaneous insulin injections.
    • Patients using inhaled insulin reported increased satisfaction levels.
    • The study identified the need for further investigation into specific aspects of inhaled insulin therapy.

    Conclusions:

    • Inhaled insulin presents a viable alternative for diabetes management, offering comparable glycemic control to injections.
    • Enhanced patient satisfaction is a notable benefit of inhaled insulin.
    • Further research is essential to fully understand compliance, side-effect profiles, quality of life, long-term glycemic control, and cost-effectiveness.